{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T00:03:33Z","timestamp":1792627413501,"version":"4.5.0"},"reference-count":27,"publisher":"Informa UK Limited","issue":"24","license":[{"start":{"date-parts":[[2023,6,22]],"date-time":"2023-06-22T00:00:00Z","timestamp":1687392000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"name":"Daiichi Sankyo, Inc"}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Future Oncol."],"published-print":{"date-parts":[[2023,8]]},"DOI":"10.2217\/fon-2022-0786","type":"journal-article","created":{"date-parts":[[2023,6,22]],"date-time":"2023-06-22T09:31:47Z","timestamp":1687426307000},"page":"1677-1693","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":5,"title":["Elderly patients with acute myeloid leukemia who only receive supportive care in the Surveillance, Epidemiology and End Results-Medicare database: demographics, treatment patterns and outcomes"],"prefix":"10.1080","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3641-9738","authenticated-orcid":false,"given":"Charles","family":"Dharmani","sequence":"first","affiliation":[{"name":"Daiichi Sankyo, Inc., 211 Mt. Airy Rd.,Basking Ridge,\rNJ,\r07920USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9937-9959","authenticated-orcid":false,"given":"Eric","family":"Wang","sequence":"additional","affiliation":[{"name":"Daiichi Sankyo, Inc., 211 Mt. Airy Rd.,Basking Ridge,\rNJ,\r07920USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9034-199X","authenticated-orcid":false,"given":"Nora","family":"Tu","sequence":"additional","affiliation":[{"name":"Daiichi Sankyo, Inc., 211 Mt. Airy Rd.,Basking Ridge,\rNJ,\r07920USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2470-8276","authenticated-orcid":false,"given":"Oluwatosin","family":"Fofah","sequence":"additional","affiliation":[{"name":"Rutgers University,160 Frelinghuysen Rd, Piscataway,\rNJ 08854USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8557-2635","authenticated-orcid":false,"given":"Jenilee","family":"Cueto","sequence":"additional","affiliation":[{"name":"Daiichi Sankyo, Inc., 211 Mt. Airy Rd.,Basking Ridge,\rNJ,\r07920USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5634-1558","authenticated-orcid":false,"given":"Maribel","family":"Salas","sequence":"additional","affiliation":[{"name":"Daiichi Sankyo, Inc., 211 Mt. Airy Rd.,Basking Ridge,\rNJ,\r07920USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7001-0122","authenticated-orcid":false,"given":"Yasser Mostafa","family":"Kamel","sequence":"additional","affiliation":[{"name":"Daiichi Sankyo, Inc., 211 Mt. Airy Rd.,Basking Ridge,\rNJ,\r07920USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2023,6,22]]},"reference":[{"key":"e_1_3_5_3_1","doi-asserted-by":"publisher","DOI":"10.1242\/dmm.015974"},{"key":"e_1_3_5_4_1","volume-title":"Leukemia - Acute Myeloid - AML: Statistics.","author":"Cancer.net","year":"2023","unstructured":"Cancer.net . Leukemia - Acute Myeloid - AML: Statistics.American Society of Clinical Oncology (2023). Available at: https:\/\/www.cancer.net\/cancer-types\/leukemia-acute-myeloid-aml\/statistics#:\u223c:text=AML%20is%20the%20second%20most,of%20diagnosis%20is%20age%2068"},{"key":"e_1_3_5_5_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.blre.2019.04.005"},{"key":"e_1_3_5_6_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11912-020-00964-1"},{"key":"e_1_3_5_7_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00432-021-03756-7"},{"key":"e_1_3_5_8_1","doi-asserted-by":"publisher","DOI":"10.2217\/fon-2022-0565"},{"key":"e_1_3_5_9_1","doi-asserted-by":"publisher","DOI":"10.1155\/2010\/943823"},{"key":"e_1_3_5_10_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.2009.07663.x"},{"key":"e_1_3_5_11_1","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.24252"},{"key":"e_1_3_5_12_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.leukres.2019.05.007"},{"key":"e_1_3_5_13_1","doi-asserted-by":"publisher","DOI":"10.1182\/asheducation-2014.1.14"},{"key":"e_1_3_5_14_1","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2020001920"},{"key":"e_1_3_5_15_1","unstructured":"National Cancer Institute\n. Acute Myeloid Leukemia Treatment (2022). Available at: https:\/\/www.cancer.gov\/types\/leukemia\/hp\/adult-aml-treatment-pdq"},{"key":"e_1_3_5_16_1","unstructured":"National Comprehensive Cancer Network\n. NCCN Guidelines (Version 1). (2022). Available at: https:\/\/www.nccn.org\/professionals\/physician_gls\/pdf\/aml.pdf"},{"key":"e_1_3_5_17_1","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.162.14.1597"},{"key":"e_1_3_5_18_1","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2012.066100"},{"key":"e_1_3_5_19_1","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2018019125"},{"key":"e_1_3_5_20_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40258-013-0032-2"},{"key":"e_1_3_5_21_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00277-015-2351-x"},{"key":"e_1_3_5_22_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2018-99-111281"},{"key":"e_1_3_5_23_1","volume-title":"Surveillance, Epidemiology and End Results Program","year":"2023","unstructured":"Surveillance, Epidemiology and End Results Program. National Cancer Institute (2023). Available at: https:\/\/seer.cancer.gov\/about\/"},{"key":"e_1_3_5_24_1","volume-title":"What\u2019s Medicare?","year":"2023","unstructured":"What\u2019s Medicare? Medicare.gov (2023). Available at: https:\/\/www.medicare.gov\/what-medicare-covers\/your-medicare-coverage-choices\/whats-medicare"},{"key":"e_1_3_5_25_1","unstructured":"National Cancer Institute\n. SEER-Medicare: Brief Description of the SEER-Medicare Database. (2023). Available at: https:\/\/healthcaredelivery.cancer.gov\/seermedicare\/overview\/"},{"key":"e_1_3_5_26_1","unstructured":"National Comprehensive Cancer Network\n. Acute Myeloid Leukemia. (Version 3). (2020). Available at: https:\/\/www.nccn.org\/professionals\/physician_gls\/pdf\/aml.pdf"},{"key":"e_1_3_5_27_1","unstructured":"National Comprehensive Cancer Network\n. Palliative Care. (Version 1). (2020). Available at: https:\/\/www.nccn.org\/professionals\/physician_gls\/pdf\/palliative.pdf"},{"key":"e_1_3_5_28_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2014-02-514778"},{"key":"e_1_3_5_29_1","unstructured":"US FDA Center for Drug Evaluation and Research\n. FDA grants regular approval to venetoclax in combination for untreated acute myeloid leukemia. (2020). Available at: https:\/\/www.fda.gov\/drugs\/resources-information-approved-drugs\/fda-grants-regular-approval-venetoclax-combination-untreated-acute-myeloid-leukemia"}],"container-title":["Future Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.2217\/fon-2022-0786","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,23]],"date-time":"2024-06-23T06:44:46Z","timestamp":1719125086000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.2217\/fon-2022-0786"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6,22]]},"references-count":27,"journal-issue":{"issue":"24","published-print":{"date-parts":[[2023,8]]}},"alternative-id":["10.2217\/fon-2022-0786"],"URL":"https:\/\/doi.org\/10.2217\/fon-2022-0786","relation":{},"ISSN":["1479-6694","1744-8301"],"issn-type":[{"value":"1479-6694","type":"print"},{"value":"1744-8301","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,6,22]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ifon20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ifon20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2022-08-08","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-05-25","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-06-22","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}